| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | ATG5 TRIM49 FBXW8 HECW2 UBR4 ZFP91 TRIM49C TRIM31 TRIM49D1 HECTD1 DDB2 | 9.70e-06 | 512 | 84 | 11 | GO:0019787 |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | ATG5 TRIM49 FBXW8 HECW2 UBR4 ZFP91 TRIM49C TRIM31 TRIM49D1 HECTD1 DDB2 | 1.39e-05 | 532 | 84 | 11 | GO:0016755 |
| GeneOntologyMolecularFunction | acyltransferase activity | ATG5 TRIM49 FBXW8 ACSM3 MBOAT1 HECW2 UBR4 ZFP91 TRIM49C TRIM31 TRIM49D1 HECTD1 DDB2 | 2.01e-05 | 775 | 84 | 13 | GO:0016746 |
| GeneOntologyMolecularFunction | ubiquitin-protein transferase activity | TRIM49 FBXW8 HECW2 UBR4 ZFP91 TRIM49C TRIM31 TRIM49D1 HECTD1 DDB2 | 2.91e-05 | 473 | 84 | 10 | GO:0004842 |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | 4.47e-05 | 398 | 84 | 9 | GO:0061659 | |
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 4.68e-05 | 17 | 84 | 3 | GO:0046703 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | 1.71e-04 | 372 | 84 | 8 | GO:0061630 | |
| GeneOntologyMolecularFunction | vinculin binding | 1.32e-03 | 13 | 84 | 2 | GO:0017166 | |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | ATG5 TRIM49 IFIH1 KCTD9 FBXW8 USP11 HECW2 UBR4 ZFP91 TRIM49C TRIM31 TRIM49D1 BCL11A ASB15 PSMD14 HECTD1 DDB2 | 4.42e-07 | 1009 | 83 | 17 | GO:0070647 |
| GeneOntologyBiologicalProcess | post-translational protein modification | ATG5 TRIM49 IFIH1 KCTD9 FBXW8 USP11 HECW2 UBR4 ZFP91 TRIM49C TRIM31 TRIM49D1 BCL11A ASB15 PSMD14 HECTD1 DDB2 | 1.05e-06 | 1074 | 83 | 17 | GO:0043687 |
| GeneOntologyBiologicalProcess | cellular response to exogenous dsRNA | 1.69e-06 | 22 | 83 | 4 | GO:0071360 | |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation | ATG5 TRIM49 IFIH1 KCTD9 FBXW8 HECW2 UBR4 ZFP91 TRIM49C TRIM31 TRIM49D1 BCL11A ASB15 HECTD1 DDB2 | 2.42e-06 | 893 | 83 | 15 | GO:0032446 |
| GeneOntologyBiologicalProcess | cellular response to dsRNA | 4.64e-06 | 28 | 83 | 4 | GO:0071359 | |
| GeneOntologyBiologicalProcess | susceptibility to natural killer cell mediated cytotoxicity | 5.19e-06 | 9 | 83 | 3 | GO:0042271 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous antigen | 8.04e-06 | 32 | 83 | 4 | GO:0019883 | |
| GeneOntologyBiologicalProcess | protein ubiquitination | ATG5 TRIM49 KCTD9 FBXW8 HECW2 UBR4 ZFP91 TRIM49C TRIM31 TRIM49D1 ASB15 HECTD1 DDB2 | 2.03e-05 | 811 | 83 | 13 | GO:0016567 |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent | 3.39e-05 | 16 | 83 | 3 | GO:0002486 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway | 4.10e-05 | 17 | 83 | 3 | GO:0002484 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib | 4.10e-05 | 17 | 83 | 3 | GO:0002476 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class Ib | 4.91e-05 | 18 | 83 | 3 | GO:0002428 | |
| GeneOntologyBiologicalProcess | response to exogenous dsRNA | 7.11e-05 | 55 | 83 | 4 | GO:0043330 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I | 1.05e-04 | 23 | 83 | 3 | GO:0019885 | |
| GeneOntologyBiologicalProcess | response to dsRNA | 1.21e-04 | 63 | 83 | 4 | GO:0043331 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen | 1.36e-04 | 25 | 83 | 3 | GO:0002483 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation via MHC class Ib | 1.36e-04 | 25 | 83 | 3 | GO:0002475 | |
| GeneOntologyBiologicalProcess | positive regulation of nitric oxide biosynthetic process | 1.37e-04 | 65 | 83 | 4 | GO:0045429 | |
| GeneOntologyBiologicalProcess | positive regulation of nitric oxide metabolic process | 1.54e-04 | 67 | 83 | 4 | GO:1904407 | |
| GeneOntologyBiologicalProcess | positive regulation of response to tumor cell | 1.91e-04 | 28 | 83 | 3 | GO:0002836 | |
| GeneOntologyBiologicalProcess | positive regulation of immune response to tumor cell | 1.91e-04 | 28 | 83 | 3 | GO:0002839 | |
| GeneOntologyBiologicalProcess | regulation of dendrite development | 3.50e-04 | 150 | 83 | 5 | GO:0050773 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell activation | 3.75e-04 | 35 | 83 | 3 | GO:0032816 | |
| GeneOntologyBiologicalProcess | cilium assembly | 4.17e-04 | 444 | 83 | 8 | GO:0060271 | |
| GeneOntologyBiologicalProcess | maternal process involved in parturition | 4.41e-04 | 8 | 83 | 2 | GO:0060137 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell mediated cytotoxicity | 5.58e-04 | 40 | 83 | 3 | GO:0045954 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class I | 6.00e-04 | 41 | 83 | 3 | GO:0002474 | |
| GeneOntologyBiologicalProcess | regulation of nitric oxide biosynthetic process | 6.36e-04 | 97 | 83 | 4 | GO:0045428 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated cytotoxicity | 6.44e-04 | 42 | 83 | 3 | GO:0001916 | |
| GeneOntologyBiologicalProcess | positive regulation of macrophage activation | 6.44e-04 | 42 | 83 | 3 | GO:0043032 | |
| GeneOntologyBiologicalProcess | cilium organization | 6.58e-04 | 476 | 83 | 8 | GO:0044782 | |
| GeneOntologyBiologicalProcess | regulation of nitric oxide metabolic process | 7.13e-04 | 100 | 83 | 4 | GO:0080164 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell mediated immunity | 7.39e-04 | 44 | 83 | 3 | GO:0002717 | |
| GeneOntologyCellularComponent | rough endoplasmic reticulum lumen | 1.58e-04 | 5 | 84 | 2 | GO:0048237 | |
| Domain | Sox7/17/18_central | 5.98e-05 | 3 | 84 | 2 | IPR033392 | |
| Domain | Sox17_18_mid | 5.98e-05 | 3 | 84 | 2 | PF12067 | |
| Domain | Sox_C | 5.98e-05 | 3 | 84 | 2 | IPR021934 | |
| Domain | SOX_C | 5.98e-05 | 3 | 84 | 2 | PS51516 | |
| Domain | MHC_I | 1.10e-04 | 21 | 84 | 3 | PF00129 | |
| Domain | MHC_I_a_a1/a2 | 1.10e-04 | 21 | 84 | 3 | IPR001039 | |
| Domain | - | 1.66e-04 | 24 | 84 | 3 | 3.30.500.10 | |
| Domain | MHC_I-like_Ag-recog | 1.66e-04 | 24 | 84 | 3 | IPR011161 | |
| Domain | BBOX | 2.63e-04 | 69 | 84 | 4 | SM00336 | |
| Domain | Butyrophylin | 2.78e-04 | 70 | 84 | 4 | IPR003879 | |
| Domain | - | 2.94e-04 | 71 | 84 | 4 | 4.10.45.10 | |
| Domain | DUF3398 | 2.96e-04 | 6 | 84 | 2 | PF11878 | |
| Domain | DOCK_C/D_N | 2.96e-04 | 6 | 84 | 2 | IPR021816 | |
| Domain | zf-B_box | 3.10e-04 | 72 | 84 | 4 | PF00643 | |
| Domain | ZF_BBOX | 4.64e-04 | 80 | 84 | 4 | PS50119 | |
| Domain | Znf_B-box | 4.87e-04 | 81 | 84 | 4 | IPR000315 | |
| Domain | SPRY | 6.38e-04 | 87 | 84 | 4 | SM00449 | |
| Domain | MHC_I/II-like_Ag-recog | 6.61e-04 | 38 | 84 | 3 | IPR011162 | |
| Domain | SPRY | 8.54e-04 | 94 | 84 | 4 | PF00622 | |
| Domain | SPRY_dom | 8.54e-04 | 94 | 84 | 4 | IPR003877 | |
| Domain | B30.2/SPRY | 8.88e-04 | 95 | 84 | 4 | IPR001870 | |
| Domain | B302_SPRY | 8.88e-04 | 95 | 84 | 4 | PS50188 | |
| Domain | DOCK_C | 1.07e-03 | 11 | 84 | 2 | IPR010703 | |
| Domain | DHR-1_domain | 1.07e-03 | 11 | 84 | 2 | IPR027007 | |
| Domain | DHR_2 | 1.07e-03 | 11 | 84 | 2 | PS51651 | |
| Domain | DHR_1 | 1.07e-03 | 11 | 84 | 2 | PS51650 | |
| Domain | DOCK-C2 | 1.07e-03 | 11 | 84 | 2 | PF14429 | |
| Domain | DHR-2 | 1.07e-03 | 11 | 84 | 2 | IPR027357 | |
| Domain | DHR-2 | 1.07e-03 | 11 | 84 | 2 | PF06920 | |
| Domain | DOCK | 1.07e-03 | 11 | 84 | 2 | IPR026791 | |
| Domain | Quinoprot_gluc/sorb_DH | 1.28e-03 | 12 | 84 | 2 | IPR011041 | |
| Domain | Ferritin-like_SF | 1.76e-03 | 14 | 84 | 2 | IPR009078 | |
| Domain | IG_MHC | 2.50e-03 | 60 | 84 | 3 | PS00290 | |
| Domain | CH | 3.14e-03 | 65 | 84 | 3 | SM00033 | |
| Domain | CH | 3.87e-03 | 70 | 84 | 3 | PF00307 | |
| Domain | - | 4.02e-03 | 71 | 84 | 3 | 1.10.418.10 | |
| Domain | CH | 4.35e-03 | 73 | 84 | 3 | PS50021 | |
| Domain | CH-domain | 4.69e-03 | 75 | 84 | 3 | IPR001715 | |
| Domain | Actinin_actin-bd_CS | 4.76e-03 | 23 | 84 | 2 | IPR001589 | |
| Domain | Spectrin | 4.76e-03 | 23 | 84 | 2 | PF00435 | |
| Domain | ACTININ_2 | 4.76e-03 | 23 | 84 | 2 | PS00020 | |
| Domain | ACTININ_1 | 4.76e-03 | 23 | 84 | 2 | PS00019 | |
| Domain | HECT | 6.52e-03 | 27 | 84 | 2 | PF00632 | |
| Domain | HECTc | 6.52e-03 | 27 | 84 | 2 | SM00119 | |
| Domain | HECT_dom | 6.52e-03 | 27 | 84 | 2 | IPR000569 | |
| Domain | HECT | 6.52e-03 | 27 | 84 | 2 | PS50237 | |
| Domain | Spectrin_repeat | 7.50e-03 | 29 | 84 | 2 | IPR002017 | |
| Pubmed | 1.46e-08 | 3 | 86 | 3 | 25212604 | ||
| Pubmed | Direct interaction of the mouse cytomegalovirus m152/gp40 immunoevasin with RAE-1 isoforms. | 5.83e-08 | 4 | 86 | 3 | 20166740 | |
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 8882725 | ||
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 12421908 | ||
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 12756263 | ||
| Pubmed | 5.83e-08 | 4 | 86 | 3 | 19081632 | ||
| Pubmed | MULT1E/mIL-12: a novel bifunctional protein for natural killer cell activation. | 1.45e-07 | 5 | 86 | 3 | 24572784 | |
| Pubmed | 1.45e-07 | 5 | 86 | 3 | 8982867 | ||
| Pubmed | Crystal structures of RAE-1beta and its complex with the activating immunoreceptor NKG2D. | 2.90e-07 | 6 | 86 | 3 | 11825567 | |
| Pubmed | 2.90e-07 | 6 | 86 | 3 | 20219610 | ||
| Pubmed | 2.90e-07 | 6 | 86 | 3 | 20976056 | ||
| Pubmed | 2.90e-07 | 6 | 86 | 3 | 10894171 | ||
| Pubmed | Polymorphisms of NKG2D ligands: diverse RAET1/ULBP genes in northeastern Thais. | 2.90e-07 | 6 | 86 | 3 | 19688209 | |
| Pubmed | Ligands for murine NKG2D display heterogeneous binding behavior. | 2.90e-07 | 6 | 86 | 3 | 11857333 | |
| Pubmed | The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60. | 5.07e-07 | 7 | 86 | 3 | 16831899 | |
| Pubmed | 5.07e-07 | 7 | 86 | 3 | 20870941 | ||
| Pubmed | 5.07e-07 | 7 | 86 | 3 | 26151313 | ||
| Pubmed | NKG2D and Its Ligand MULT1 Contribute to Disease Progression in a Mouse Model of Multiple Sclerosis. | 5.07e-07 | 7 | 86 | 3 | 30787931 | |
| Pubmed | 5.07e-07 | 7 | 86 | 3 | 12370332 | ||
| Pubmed | 5.07e-07 | 7 | 86 | 3 | 25583577 | ||
| Pubmed | A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity. | 8.10e-07 | 8 | 86 | 3 | 12645935 | |
| Pubmed | Gut microbiota regulates NKG2D ligand expression on intestinal epithelial cells. | 1.21e-06 | 9 | 86 | 3 | 23136011 | |
| Pubmed | Cutting edge: Toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor. | 1.21e-06 | 9 | 86 | 3 | 14764662 | |
| Pubmed | A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3. | 1.73e-06 | 10 | 86 | 3 | 11827464 | |
| Pubmed | Cell Surface Downregulation of NK Cell Ligands by Patient-Derived HIV-1 Vpu and Nef Alleles. | 2.37e-06 | 11 | 86 | 3 | 26656785 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | ATG5 GTF2A1 FAM114A1 NCAPG GOPC USP11 UBR4 IREB2 RECQL ACTN1 NUDCD3 PSMD14 HECTD1 DDB2 CHUK | 2.61e-06 | 1455 | 86 | 15 | 22863883 |
| Pubmed | ATG5 DLGAP1 CFAP91 ZBTB38 USP11 SYNE1 UBR4 CEP290 YLPM1 LRPAP1 POGZ ACTN1 HECTD1 CHUK | 3.12e-06 | 1285 | 86 | 14 | 35914814 | |
| Pubmed | 3.35e-06 | 486 | 86 | 9 | 20936779 | ||
| Pubmed | 6.04e-06 | 2 | 86 | 2 | 29260931 | ||
| Pubmed | 6.50e-06 | 15 | 86 | 3 | 19703589 | ||
| Pubmed | Identification of a genomic reservoir for new TRIM genes in primate genomes. | 1.37e-05 | 19 | 86 | 3 | 22144910 | |
| Pubmed | ATG5 KCTD9 GTF2A1 FAM114A1 RSPH3 GOPC SULT2B1 TCHP FAM13C DOCK8 LENG1 POGZ ACTN1 PTCD3 | 1.51e-05 | 1477 | 86 | 14 | 31515488 | |
| Pubmed | Trichoplein controls microtubule anchoring at the centrosome by binding to Odf2 and ninein. | 1.81e-05 | 3 | 86 | 2 | 21325031 | |
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 17897950 | ||
| Pubmed | 1.81e-05 | 3 | 86 | 2 | 34570228 | ||
| Pubmed | 3.17e-05 | 645 | 86 | 9 | 25281560 | ||
| Pubmed | 3.49e-05 | 653 | 86 | 9 | 22586326 | ||
| Pubmed | PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase. | 3.53e-05 | 247 | 86 | 6 | 32989298 | |
| Pubmed | Redundant roles of Sox17 and Sox18 in early cardiovascular development of mouse embryos. | 3.61e-05 | 4 | 86 | 2 | 17610846 | |
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 29717061 | ||
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 19424970 | ||
| Pubmed | 3.61e-05 | 4 | 86 | 2 | 28619820 | ||
| Pubmed | 6.01e-05 | 5 | 86 | 2 | 19658097 | ||
| Pubmed | 6.01e-05 | 5 | 86 | 2 | 9271224 | ||
| Pubmed | 6.01e-05 | 5 | 86 | 2 | 18587224 | ||
| Pubmed | GOPC DOCK8 ZFP91 RBM5 ELF1 RECQL POGZ BCL11A ACTN1 PSMD14 MIDEAS | 8.65e-05 | 1103 | 86 | 11 | 34189442 | |
| Pubmed | 9.01e-05 | 6 | 86 | 2 | 19515696 | ||
| Pubmed | 9.01e-05 | 6 | 86 | 2 | 29635272 | ||
| Pubmed | Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. | 9.01e-05 | 6 | 86 | 2 | 16177806 | |
| Pubmed | Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity. | 9.34e-05 | 95 | 86 | 4 | 29643511 | |
| Pubmed | A transition zone complex regulates mammalian ciliogenesis and ciliary membrane composition. | 1.07e-04 | 37 | 86 | 3 | 21725307 | |
| Pubmed | Proximity interactions among centrosome components identify regulators of centriole duplication. | 1.19e-04 | 101 | 86 | 4 | 24613305 | |
| Pubmed | BBS mutations modify phenotypic expression of CEP290-related ciliopathies. | 1.26e-04 | 7 | 86 | 2 | 23943788 | |
| Pubmed | 1.26e-04 | 7 | 86 | 2 | 18288386 | ||
| Pubmed | 1.26e-04 | 7 | 86 | 2 | 28577909 | ||
| Pubmed | 1.26e-04 | 7 | 86 | 2 | 28559451 | ||
| Pubmed | 1.56e-04 | 622 | 86 | 8 | 14574404 | ||
| Pubmed | A conserved family of genes related to the testis determining gene, SRY. | 1.68e-04 | 8 | 86 | 2 | 1614875 | |
| Pubmed | 1.68e-04 | 8 | 86 | 2 | 9852162 | ||
| Pubmed | NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways. | 1.68e-04 | 8 | 86 | 2 | 20434986 | |
| Pubmed | 1.94e-04 | 481 | 86 | 7 | 28190767 | ||
| Pubmed | 2.15e-04 | 9 | 86 | 2 | 11732910 | ||
| Pubmed | Human immunodeficiency virus type 1 Vpr links proteasomal degradation and checkpoint activation. | 2.15e-04 | 9 | 86 | 2 | 17855541 | |
| Pubmed | 2.37e-04 | 497 | 86 | 7 | 23414517 | ||
| Pubmed | CFAP61 is required for sperm flagellum formation and male fertility in human and mouse. | 2.68e-04 | 10 | 86 | 2 | 34792097 | |
| Pubmed | 2.68e-04 | 10 | 86 | 2 | 27979967 | ||
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 2.84e-04 | 232 | 86 | 5 | 25515538 | |
| Pubmed | GTF2A1 NCAPG GOPC TCHP USP11 SYNE1 UBR4 EXOC3 LRPAP1 NUDCD3 PTCD3 NIN | 2.92e-04 | 1487 | 86 | 12 | 33957083 | |
| Pubmed | The expression of Sox17 identifies and regulates haemogenic endothelium. | 3.28e-04 | 11 | 86 | 2 | 23604320 | |
| Pubmed | 3.28e-04 | 11 | 86 | 2 | 24550735 | ||
| Pubmed | 3.28e-04 | 11 | 86 | 2 | 25552655 | ||
| Pubmed | 3.65e-04 | 534 | 86 | 7 | 35032548 | ||
| Pubmed | Essential and overlapping functions for mammalian Argonautes in microRNA silencing. | 3.93e-04 | 12 | 86 | 2 | 19174539 | |
| Pubmed | Redundant roles of Sox17 and Sox18 in postnatal angiogenesis in mice. | 3.93e-04 | 12 | 86 | 2 | 16895970 | |
| Pubmed | HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1. | 3.93e-04 | 12 | 86 | 2 | 17360488 | |
| Pubmed | 4.31e-04 | 549 | 86 | 7 | 38280479 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 4.46e-04 | 394 | 86 | 6 | 27248496 | |
| Pubmed | 4.63e-04 | 13 | 86 | 2 | 29898395 | ||
| Pubmed | 4.63e-04 | 13 | 86 | 2 | 22962592 | ||
| Pubmed | Cep120 and TACCs control interkinetic nuclear migration and the neural progenitor pool. | 4.63e-04 | 13 | 86 | 2 | 17920017 | |
| Pubmed | 4.68e-04 | 733 | 86 | 8 | 34672954 | ||
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | 4.83e-04 | 400 | 86 | 6 | 35013556 | |
| Pubmed | A set of proteins interacting with transcription factor Sp1 identified in a two-hybrid screening. | 5.39e-04 | 14 | 86 | 2 | 10976766 | |
| Pubmed | 5.39e-04 | 14 | 86 | 2 | 8921394 | ||
| Pubmed | Molecular dissection of plasmacytoid dendritic cell activation in vivo during a viral infection. | 5.39e-04 | 14 | 86 | 2 | 30131424 | |
| Pubmed | Condensin I and II Complexes License Full Estrogen Receptor α-Dependent Enhancer Activation. | 5.39e-04 | 14 | 86 | 2 | 26166704 | |
| Pubmed | The SRF target gene Fhl2 antagonizes RhoA/MAL-dependent activation of SRF. | 5.39e-04 | 14 | 86 | 2 | 15610731 | |
| Pubmed | 5.39e-04 | 14 | 86 | 2 | 12432077 | ||
| Pubmed | Activation of the NF-kappaB pathway by caspase 8 and its homologs. | 6.21e-04 | 15 | 86 | 2 | 11002417 | |
| Pubmed | Sox7, Sox17, and Sox18 Cooperatively Regulate Vascular Development in the Mouse Retina. | 6.21e-04 | 15 | 86 | 2 | 26630461 | |
| Pubmed | C2cd3 is critical for centriolar distal appendage assembly and ciliary vesicle docking in mammals. | 6.21e-04 | 15 | 86 | 2 | 24469809 | |
| Pubmed | 6.21e-04 | 15 | 86 | 2 | 28512199 | ||
| Pubmed | 6.21e-04 | 15 | 86 | 2 | 29882512 | ||
| Pubmed | 6.21e-04 | 15 | 86 | 2 | 19793892 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 6.46e-04 | 588 | 86 | 7 | 38580884 | |
| Pubmed | Coronary veins determine the pattern of sympathetic innervation in the developing heart. | 7.09e-04 | 16 | 86 | 2 | 23462468 | |
| Pubmed | 7.09e-04 | 16 | 86 | 2 | 29979702 | ||
| Pubmed | A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition. | 7.13e-04 | 431 | 86 | 6 | 33660365 | |
| Pubmed | KIAA1671 USP11 UBR4 YLPM1 ZFP91 ELF1 POGZ BCL11A PSMD14 MIDEAS PTCD3 | 7.86e-04 | 1429 | 86 | 11 | 35140242 | |
| Pubmed | 8.02e-04 | 17 | 86 | 2 | 24947469 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q25 | 1.51e-05 | 164 | 86 | 5 | chr6q25 | |
| Cytoband | 6q25 | 2.26e-04 | 12 | 86 | 2 | 6q25 | |
| Cytoband | 11q14.3 | 1.66e-03 | 32 | 86 | 2 | 11q14.3 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 2.28e-04 | 95 | 57 | 4 | 59 | |
| GeneFamily | SRY-boxes | 1.61e-03 | 19 | 57 | 2 | 757 | |
| GeneFamily | Bardet-Biedl syndrome associated|BBSome | 1.97e-03 | 21 | 57 | 2 | 980 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.09e-08 | 188 | 86 | 7 | 117dc80fa940e6aa1b0187a43fdde33f3fcb578f | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.11e-07 | 197 | 86 | 7 | b2b7f8dc8ca421441e4c99c4f5d18fbc1668d79f | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.40e-06 | 181 | 86 | 6 | 2c660fcf0404c155955b67ab2958d6e6b0e30024 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.81e-06 | 189 | 86 | 6 | 9e58411e51019ca59e78d3e737d65d2bcbbea2be | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_cycling-endo_proliferating1_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.86e-06 | 190 | 86 | 6 | 9a2244c3973aee7270646bf00db7727edb9decc5 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Control / Disease state, Lineage and Cell class | 1.92e-06 | 191 | 86 | 6 | 322237793a1278bafb14e63cab688b353e352dcc | |
| ToppCell | facs-Lung-Endomucin_-18m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-06 | 192 | 86 | 6 | ba3fe97786564dba1c8185f2802ce1b57f4f3cc9 | |
| ToppCell | facs-Lung-Endomucin_|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-06 | 192 | 86 | 6 | 85d4d0df701451daf95e94a87a0096da1e86533b | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-06 | 193 | 86 | 6 | 54024a373e42e1c0bcc327dc084564b83b63a9d4 | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-06 | 193 | 86 | 6 | 81d908594d2983ba7e7c1ec25afdde4315d9690e | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature-endo_capillary_(2)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.04e-06 | 193 | 86 | 6 | 4f38aae346ea3b4258744e9dc1e5aeb4fea13d06 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature4_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.04e-06 | 193 | 86 | 6 | 72d20ee257149b238016b44d183ce3fc24b8f621 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.04e-06 | 193 | 86 | 6 | ff6e6b825d6c88148216c601580be3c28851ab5c | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-endo_capillary_(2)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.10e-06 | 194 | 86 | 6 | 3c31ac44e8cf4eca3ba7b8bfc05ad3e96a970956 | |
| ToppCell | PCW_05-06-Endothelial|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.10e-06 | 194 | 86 | 6 | 00291c62795a55a7e63b1db10c139d6a3298e55e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.10e-06 | 194 | 86 | 6 | 78dcb9d48259afabe73b41c5508a73a8d62339a4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.10e-06 | 194 | 86 | 6 | ea5e1bc8d9e27cabfe1fb833ca47ec0893593b12 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_immature|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.10e-06 | 194 | 86 | 6 | 9bd25ea57f2da27bd200d1a8bf797fec77d172c7 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.10e-06 | 194 | 86 | 6 | cceb7c88492bb6cd531e1c2651638da1ddf30931 | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial-Cd36+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-06 | 194 | 86 | 6 | 74d0eaa76f6d9af14110dfe5b4bf9751b99ff6e3 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.16e-06 | 195 | 86 | 6 | 54fde2cfa51ab3a2d48d2426494ca6f0ce77f725 | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.16e-06 | 195 | 86 | 6 | a432d69b0172211ee4d53675936a1dc9ce1ae1f0 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature2_(1)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.23e-06 | 196 | 86 | 6 | b0288e28a6e6222a9e310eb6fe228c04b618db13 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-endo_capillary_(2)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.23e-06 | 196 | 86 | 6 | 2a2a93b89dcb98043cb1f8b422ac8c55e2edc37b | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature-endo_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.23e-06 | 196 | 86 | 6 | 29ed8b1c4cd730db8632fde6eece404f1883a86d | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.23e-06 | 196 | 86 | 6 | 686533fd3fba8e4df96b9dd1307e870e89db4332 | |
| ToppCell | Fetal_29-31_weeks-Endothelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.23e-06 | 196 | 86 | 6 | 3981f6c7487598f4f7ce4650ac0ac5bd41481d66 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature-endo_immature2_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.23e-06 | 196 | 86 | 6 | 0e8d649b50be2d707510b897bb97767b5847dff9 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.29e-06 | 197 | 86 | 6 | 4e9221cb02122aed2981c3c9157e847a3710e323 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-tip_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.29e-06 | 197 | 86 | 6 | b212ff28ca2d1fea4140f186ab90941bdca21249 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.29e-06 | 197 | 86 | 6 | 9b3d6fe76dd7d61a286a28d9466b5f2fece048e1 | |
| ToppCell | wk_15-18-Endothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.36e-06 | 198 | 86 | 6 | dcf453e22dba90c0ae349fa6c3d4c20758bb95af | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-intermediate_cap|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.36e-06 | 198 | 86 | 6 | 75270600b5b29187dfa86f01f8f927ae0621cda4 | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_capillary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.43e-06 | 199 | 86 | 6 | 772b3f60b83e29b958e1e70dadfd9f058ed4cb7c | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.50e-06 | 200 | 86 | 6 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.50e-06 | 200 | 86 | 6 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.50e-06 | 200 | 86 | 6 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.50e-06 | 200 | 86 | 6 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_capillary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.50e-06 | 200 | 86 | 6 | 746e8f61411f8e68b988152ab36561991f716a0a | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.50e-06 | 200 | 86 | 6 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.50e-06 | 200 | 86 | 6 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.03e-05 | 171 | 86 | 5 | b3e6e31dfe3623b960ccf692fdbd236fa4039923 | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_28|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.15e-05 | 173 | 86 | 5 | 66488d01e03264fb193285470901c9c4182fbae8 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-05 | 175 | 86 | 5 | 12f5fd83c7710fc0c77406f765d9cbd133433b8b | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-05 | 175 | 86 | 5 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_LINC00507_CTXN3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.40e-05 | 177 | 86 | 5 | 96d639407f79669f3990138793d157b94273581c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L5-6_RORB_LINC00320|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.40e-05 | 177 | 86 | 5 | 01df8ab3285fa66b4805c555cfbfc4b3b16db919 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.60e-05 | 180 | 86 | 5 | 5861b44acfb8fe92c281c8355bf19c059b3dcd64 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations) | 2.67e-05 | 181 | 86 | 5 | 26eb4ee57a70dbf54e096b73129fda9dfda1f6ec | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.74e-05 | 182 | 86 | 5 | 63b41b538b26bc899558807fd035e543611f8c52 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.96e-05 | 185 | 86 | 5 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class | 2.96e-05 | 185 | 86 | 5 | a28187c2fd23564314b35759479ff2ca21f61485 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 3.12e-05 | 187 | 86 | 5 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 187 | 86 | 5 | 52ffd4be374e329ac8d321063f061b826d252956 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.12e-05 | 187 | 86 | 5 | d9d10ed7c905778a29a0dc3ced3eef02a6b1de5c | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_mature-endo_capillary_(2)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.12e-05 | 187 | 86 | 5 | 106f50ad85a92403037214f0e94702230284837f | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Control / Disease state, Lineage and Cell class | 3.12e-05 | 187 | 86 | 5 | 54d7588172ac145ff5045ad9771636729ca3f0ca | |
| ToppCell | wk_08-11-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.12e-05 | 187 | 86 | 5 | a27aa97aa6508a3ffe92c2b6bb0511a95650a390 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.20e-05 | 188 | 86 | 5 | 366a2d59b9c81d8a7659749f9c07efa46b49a39a | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.20e-05 | 188 | 86 | 5 | 0026c9479b30fb39daa91cfa220a88f9c9e65fe7 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_immature-endo_immature4_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.20e-05 | 188 | 86 | 5 | b9c5d573fc5ab0f7f38c55d006f9576634b05462 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.28e-05 | 189 | 86 | 5 | db09d591b885ce2bc9e353f08b6694e2192582e1 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.28e-05 | 189 | 86 | 5 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | COVID-19-Heart-EC_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.28e-05 | 189 | 86 | 5 | fe49852ba15f948b384d6b4c258927c70b741357 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.28e-05 | 189 | 86 | 5 | a34f008dfcee4012977bbc5b60de6f0329ca2f65 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 3.36e-05 | 190 | 86 | 5 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.36e-05 | 190 | 86 | 5 | 06bfb62b94b0faf467ef93d5bc5d08924c770098 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.36e-05 | 190 | 86 | 5 | 0e9847d7f49b2236b8a191e1a7df37556351ba9e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.36e-05 | 190 | 86 | 5 | 5681c211baeed4af82a2bbc13420f6a7b487581c | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-05 | 190 | 86 | 5 | e64b191f928935484e2c993d7f8af0572a617a3a | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_cycling-endo_proliferating1_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.45e-05 | 191 | 86 | 5 | edfd5eeff69b5de19c5df3d899e42acd7e015913 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.45e-05 | 191 | 86 | 5 | 1de0bdfd13bd930691564c2673f2e66393bc0255 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 3.45e-05 | 191 | 86 | 5 | c672c8e28d06d555335976b3f8bd2ea6d3b34aae | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.45e-05 | 191 | 86 | 5 | e3fc5c92491b6e334abffbf085c00a0b5fa1aed2 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature3_(11)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.54e-05 | 192 | 86 | 5 | 7dbe3117a0f58ff2e838963d49f788a59a4351d7 | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-05 | 192 | 86 | 5 | 45929c757d873fe314cc36d27abd265414635490 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_cycling-endo_proliferating2_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.54e-05 | 192 | 86 | 5 | ac3d87aa301d30515c369bd7fc16f33b82173a85 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.54e-05 | 192 | 86 | 5 | 5a0615fdc217554ccd611504b16e5d97628e207d | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.54e-05 | 192 | 86 | 5 | 7197e401e563441ab94815f7619e032ebef9e586 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.54e-05 | 192 | 86 | 5 | 1f35efb0765e05f7f9c881849953bef3965be25a | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.54e-05 | 192 | 86 | 5 | 6c089bde63dd5f16a07c5929fb49df600f0b21ab | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-05 | 192 | 86 | 5 | beb336d3479821bdab7e8e2c58812f155e44e9a2 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_immature-endo_immature1_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.62e-05 | 193 | 86 | 5 | 2661ad9107ed9231e4afea4442a79051139a31df | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-05 | 193 | 86 | 5 | 2218833749576ba1a0fc95bd155c781e7e1163c6 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_cycling-endo_proliferating1_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.62e-05 | 193 | 86 | 5 | 643f992dbce639e7d147924d8b8f455fcebf215a | |
| ToppCell | IPF-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 3.62e-05 | 193 | 86 | 5 | d7750a7575ef257963b7f1c64fa67c52dbff797b | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_cycling-endo_proliferating3_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.62e-05 | 193 | 86 | 5 | f7e4a390921780587b9bd084e495e646fa1ec74f | |
| ToppCell | COPD-Endothelial|COPD / Disease state, Lineage and Cell class | 3.62e-05 | 193 | 86 | 5 | 093b28dcccb5841c995d0b33fae0efd6b88f97e0 | |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.62e-05 | 193 | 86 | 5 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.62e-05 | 193 | 86 | 5 | dd443b83d328a9069ffe19ac3d74066e922515a5 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature4_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.62e-05 | 193 | 86 | 5 | 01c71aa48875b5ad6c50cc810a72862e72f26ad0 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature1_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.71e-05 | 194 | 86 | 5 | 2e3a64bda7c76fd0c99e93de0215f236e8045d83 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_mature|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.71e-05 | 194 | 86 | 5 | 8c88a0ddd61ad900426e312ca4ab13061c0380b8 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.71e-05 | 194 | 86 | 5 | 46e36817fd1ed27af8013375214c38c9a9271640 | |
| ToppCell | IPF-Endothelial-VE_Capillary_B|IPF / Disease state, Lineage and Cell class | 3.71e-05 | 194 | 86 | 5 | 169a304d5c13f08c39fad4116f093bc4a0765e9d | |
| ToppCell | IPF-Endothelial|IPF / Disease state, Lineage and Cell class | 3.71e-05 | 194 | 86 | 5 | 9591993aa2dcba3d09a0f1ea8b8f2439c26482d6 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.71e-05 | 194 | 86 | 5 | df56e23f1dcf1902d29392fcc947e0e268e1648b | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.71e-05 | 194 | 86 | 5 | fc2e0081005c0c496e41197a2d06e4a37708221f | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature_arterial1_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.71e-05 | 194 | 86 | 5 | 32ba2cf9b8726bc3c6e9dc24b54d22ff188bb12b | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.71e-05 | 194 | 86 | 5 | eb279e0d922de921343f0ae032a809f837d915b3 | |
| Drug | methyltrichlorosilane | 1.62e-06 | 7 | 83 | 3 | CID000006399 | |
| Disease | level of UL16-binding protein 6 in blood serum | 7.82e-06 | 2 | 83 | 2 | OBA_2043185 | |
| Disease | apolipoprotein A 1 measurement | PPP1R21 GTF2A1 TMEM62 ZBTB38 YLPM1 DOCK7 DGKG TAGLN MIDEAS DDB2 | 1.33e-04 | 848 | 83 | 10 | EFO_0004614 |
| Disease | Myopia | 8.02e-04 | 15 | 83 | 2 | C0027092 | |
| Disease | myopia (is_implicated_in) | 9.14e-04 | 16 | 83 | 2 | DOID:11830 (is_implicated_in) | |
| Disease | Bardet-Biedl syndrome 1 (disorder) | 1.03e-03 | 17 | 83 | 2 | C2936862 | |
| Disease | muscular dystrophy (is_implicated_in) | 1.03e-03 | 17 | 83 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | Bardet-Biedl syndrome | 1.16e-03 | 18 | 83 | 2 | cv:C0752166 | |
| Disease | social deprivation, COVID-19 | 1.59e-03 | 21 | 83 | 2 | EFO_0009696, MONDO_0100096 | |
| Disease | Neurodevelopmental Disorders | 2.32e-03 | 93 | 83 | 3 | C1535926 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MEKTKWLDIKGNHDA | 131 | Q0P6H9 | |
| WINNLQKEKKDSHLM | 266 | Q96KV6 | |
| VSRLWGKHKNKPDMN | 246 | P32519 | |
| HEAWTDGKEAMLRQK | 406 | P12814 | |
| KRWSAMHEAAKQGRK | 176 | Q8WXK1 | |
| MKFDELHQLKANNWK | 886 | O14490 | |
| KWHSEKMAGKNLVAV | 1541 | Q5JWR5 | |
| KSQLHKKREDGEFWM | 301 | Q6MZZ7 | |
| MEKLNQLWEKAQRLH | 56 | P30533 | |
| QKKDHKQLWMGLQND | 146 | Q9H1Y0 | |
| NMKHLNARWSKLQEG | 311 | Q7Z4T9 | |
| ALKDKIEMGNKRWNS | 686 | P48200 | |
| RDMKGPAHDKLWNQL | 226 | Q9HD26 | |
| ANKQLELPRGWEMKH | 981 | Q9P2P5 | |
| EAWKMLGLFRKHNKI | 591 | Q96EY7 | |
| LAHMFKDKGVWGNKQ | 116 | Q7L273 | |
| KWAKDMNRHFSKEDI | 1071 | O00370 | |
| KNWMKGREHENASIL | 1086 | Q9BY89 | |
| LPEDLKMAWAKKAHA | 1391 | Q86VF7 | |
| KMAWAKKAHALQSEL | 1396 | Q86VF7 | |
| QSHELKVHEMLKKGW | 321 | Q8IVD9 | |
| FMQGKRQKEIWHLLK | 641 | O15111 | |
| MNILPKKSWHVRNKD | 1 | Q96BZ8 | |
| WLRLKNNMGAHEEKK | 811 | Q8NCM2 | |
| EKHMKKWHSDRVLNN | 816 | Q9H165 | |
| AKEHMLRTNWKNRKG | 186 | Q8N3Y1 | |
| EVKNAMKKLWGRNVF | 291 | Q8NH73 | |
| LKKDLINHMQSGLWA | 936 | O95206 | |
| KINDGQWHKIKIMRS | 2841 | P24043 | |
| HWMLEAQLAKIKLEK | 581 | Q6ZMI0 | |
| DGKELWNLRMHKKKV | 231 | Q92466 | |
| WMEANQKKLVIQGKH | 156 | P52756 | |
| LKDNGQIRFMKKLDW | 271 | Q3SYG4 | |
| QNRRMKWKKDHKLPN | 211 | P17483 | |
| KHPEKFNSRMKNKLW | 601 | P49619 | |
| EKQGWRHVRIKQMGK | 1206 | Q9ULT8 | |
| KDMTHWRQNTEKLDK | 1446 | Q96N67 | |
| RLTWLQNMAEKHTKK | 1641 | Q8NF50 | |
| KNEMENERWHLGKTI | 936 | Q0VF96 | |
| KDTKGAQKVINWHMK | 1336 | O15078 | |
| MWDQEKDHLKKFNEL | 86 | Q99807 | |
| WAIQMEKKAAKEGNR | 581 | Q9BYX4 | |
| AKAKRMKLHWQFSQG | 546 | Q6P9A2 | |
| HMKLLEVNWKRKGFH | 216 | Q6ZNC8 | |
| WDHRGLKFGLMQLDK | 116 | Q86SG7 | |
| DQWKMAERKLFNKGI | 831 | Q6PJG2 | |
| WDIADKKMLNKVNLG | 1721 | Q05BV3 | |
| EQHLNELMTKKWLLG | 551 | O60645 | |
| GRLMALQEDRKNKKW | 526 | Q6UWX4 | |
| AEDIMEKDWNNHKKG | 131 | P05305 | |
| EWMKLEDFQKHLDGK | 541 | Q99549 | |
| TPDKLNKAMKRAHDW | 381 | Q8IWE2 | |
| ELEQKMLLNLHKKSW | 211 | O00487 | |
| HNAELSKMLGKSWKA | 71 | Q9BT81 | |
| DMKSWGLLQKNNHKM | 316 | Q9BZY9 | |
| HREKLLQKMQSLWEK | 136 | P0CI25 | |
| DHIKGWLRMKGKDNF | 191 | O00204 | |
| GDWKKHVETNSRLMK | 916 | Q8NF91 | |
| KWLKHPGALEKQMSR | 161 | Q96S42 | |
| NQQKRLSWDKLDHLM | 1831 | Q8N4C6 | |
| LHKKWKEQAREMADT | 1276 | Q7Z3K3 | |
| RGDPNWFMKKAQEHK | 146 | Q01995 | |
| VLKWMNDLAKGRKQL | 326 | Q8NE31 | |
| NKWSHLLVQREKMKE | 171 | Q5T5J6 | |
| PMWLDKIKKRLNEHG | 511 | Q9H930 | |
| SREGWGNLKELMKHA | 201 | Q53FZ2 | |
| VKQAMQKHLLQGWLR | 261 | Q9BPX3 | |
| KWVHAEMVNKNSELK | 171 | P46063 | |
| KNKWKFHLKDGIMNL | 346 | P52655 | |
| LKDFHMADGSWKQLK | 611 | Q8WYP3 | |
| RRKKQQWEIMHKHNE | 376 | Q86UC2 | |
| HDKERLEKWLKNMKR | 31 | Q7Z6K1 | |
| HREKLLQKMQSLWEK | 136 | P0CI26 | |
| QEELRKKQKMGGFHW | 156 | Q5H9L2 | |
| NAQLHWKRMENLKEE | 71 | Q8NE00 | |
| LMDWEEAHEKNRKNK | 6 | Q9BZA0 | |
| VHPGARKMKEKWEND | 161 | Q6H3X3 | |
| EHWKKNNPKLREMEL | 141 | Q9BT92 | |
| VHPGARKMKEKWEND | 161 | Q5VY80 | |
| KLKEINKMADHWETA | 1976 | P49750 | |
| WAAEEHREKLLKKMQ | 131 | C9J1S8 | |
| HNAVLSKMLGKAWKE | 111 | P35713 | |
| LNRKGIKKWMHNIRD | 376 | Q13641 | |
| QKASLNWHMKKHDAD | 411 | Q96JP5 | |
| LKKMRKVNWRKEHGN | 931 | Q8NAP3 | |
| VHPGARKMKEKWEND | 161 | Q9BZM5 | |
| VNWIKDHLIKQGMKA | 1051 | Q5T4S7 | |
| KQHQLATKKLDLWML | 806 | P51784 |